All changes for the tissue urogenital system (236)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA281
coiled-coil domain containing 3
Molecular
kidney
Human
CCDC3
19.0% Increase Gene Expression Level
DAA275
complement component 1, q subcomponent, C chain
Molecular
kidney
Human
C1QC
27.0% Increase Gene Expression Level
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA287
creatine kinase, brain
Molecular
kidney
Human
CKB
10.0% Decrease Gene Expression Level
DAA273
cytoplasmic FMR1 interacting protein 2
Molecular
kidney
Human
CYFIP2
11.0% Decrease Gene Expression Level
DAA1062
Creatinine clearance declines
Physiological
kidney
Human
—
—
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA289
brain protein 44-like
Molecular
kidney
Human
BRP44L
9.0% Decrease Gene Expression Level
DAA272
dedicator of cytokinesis 11
Molecular
kidney
Human
DOCK11
24.0% Increase Gene Expression Level
DAA256
defensin, beta 1
Molecular
kidney
Human
DEFB1
8.0% Decrease Gene Expression Level
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA901
telomere shortening
Molecular
kidney
Human
—
—
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA269
alpha-kinase 2
Molecular
kidney
Human
ALPK2
20.0% Increase Gene Expression Level
DAA277
tyrosinase-related protein 1
Molecular
kidney
Human
TYRP1
21.0% Decrease Gene Expression Level
DAA891
Nephrons appear to fail as units
Physiological
nephron
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA281 | coiled-coil domain containing 3 | Molecular | kidney | Human | CCDC3 | 19.0% Increase Gene Expression Level | |
DAA275 | complement component 1, q subcomponent, C chain | Molecular | kidney | Human | C1QC | 27.0% Increase Gene Expression Level | |
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA287 | creatine kinase, brain | Molecular | kidney | Human | CKB | 10.0% Decrease Gene Expression Level | |
DAA273 | cytoplasmic FMR1 interacting protein 2 | Molecular | kidney | Human | CYFIP2 | 11.0% Decrease Gene Expression Level | |
DAA1062 | Creatinine clearance declines | Physiological | kidney | Human | — | — | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA289 | brain protein 44-like | Molecular | kidney | Human | BRP44L | 9.0% Decrease Gene Expression Level | |
DAA272 | dedicator of cytokinesis 11 | Molecular | kidney | Human | DOCK11 | 24.0% Increase Gene Expression Level | |
DAA256 | defensin, beta 1 | Molecular | kidney | Human | DEFB1 | 8.0% Decrease Gene Expression Level | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA901 | telomere shortening | Molecular | kidney | Human | — | — | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA269 | alpha-kinase 2 | Molecular | kidney | Human | ALPK2 | 20.0% Increase Gene Expression Level | |
DAA277 | tyrosinase-related protein 1 | Molecular | kidney | Human | TYRP1 | 21.0% Decrease Gene Expression Level | |
DAA891 | Nephrons appear to fail as units | Physiological | nephron | Human | — | — |